R&D+Innovation

R&D+Innovation

Our competitiveness is based on constant innovation in all areas of our work.

Agricultural R&D+Innovation

The aim of the Department for Agricultural Research and Development is to improve varieties of Papaver somniferum and any aspect relating to this plant. In order to achieve this, we exhaustively study a wide range of fields, including the following:

1

Genetic research with multiple genotypes tested each season.

2

Optimization of agricultural machinery, ranging from planting to harvesting processes.

3

Study and improvement of conditions for planting and harvesting; previous crops; harvest…

4

Optimal nutrient needs at each stage of poppy development.

5

Efficient use of irrigation water.

6

Study and monitoring of major pests and crop diseases.

7

Study and monitoring needs for fertilizers and phytosanitary products.

8

Biological control.

All this is done at the experimentation centers owned by Alcaliber, as well as at public institutions and organizations with which Alcaliber has maintained collaboration and technology transfer protocols for many years. Thanks to the endeavors and joint work of our company with R&D+Innovation teams and with public and private universities, Alcaliber has developed patents to monitor and combat diseases relating to crops and pest control via biological means.

All this is done at the experimentation centers owned by Alcaliber

Industrial R&D+Innovation

Our team of chemists and chemical engineers, as well as our highly trained technical support staff, work to develop innovative and more efficient processes in the production of intermediates and Active Pharmaceutical Ingredients of the highest quality.

Objectives

The main objectives of the Industrial R&D Department are:

1

To develop and implement the latest technologies at every stage of the extraction, purification and synthesis of alkaloids.

2

To increase efficiency and optimize each step of manufacturing processes.

3

To continue developing Active Pharmaceutical Ingredients with the highest standards, thus contributing to our diversification and strengthening our privileged position as a fully integrated global industry, starting with the crop field and concluding with the manufacture of Active Pharmaceutical Ingredients.

4

To study and improve all chemical pathways in the development of products, increasing end manufacturing yields in order to remain one of the most efficient and competitive companies in our sector.

The commitment, collective effort and high technological component of our activities in the field of R&D have allowed us to be awarded with public institutions funding.

  • The NALS project IDI-20160091 for the design of processes and optimization of synthesis of noroximorphone and narcotic antagonists derivatives is being co-financed by The Center for the Development of Industrial Technology (CDTI) with the support from European regional development funds (FEDER).
  • The GENOMA project IDI-2014-1240 for the breeding and purification of opium poppy is being co-financed by The Center for the Development of Industrial Technology (CDTI).
  • The DHARMA Project IDI-20170548 for the development of agro-genomics tools for the opium poppy is being co-financed by The Center for the Development of Industrial Technology (CDTI) with the support from European regional development funds (FEDER).
  • TO-0757-P03- Construction of a new Alkaloids Extraction Plant. Project co-funded by European Union.
  • The project “CANNALIBER: RESEARCH ON CULTIVATION, PROCESSING AND INDUSTRIAL EXTRACTION OF COMPOUNDS FROM CANNABIS SATIVA” has been co-financed by the European Regional Development Fund and ICEX/Invest in Spain.
  • Project iBreed – IDI-20180973: The iBreed project consists of the development of biotechnological tools for the genetic improvement of opium poppy.Budget: EUR 1,495,867.00. Amount of partially repayable aid: EUR 1,271,486.95. Implementation period: 01-06-2018 to 30-05-2021. Place of execution: Albacete. Project co-financed by CDTI and European Union ERDF funds.
  • TO-810-P03- New manufacturing plant for high value-added products and innovatio
  • Project: CREATION AN AVANCED LABORATORY TO MICROBIOLOGY. Project co-financed by CDTI and FEDER. Place of execution: Toledo (Castilla-La Mancha). Implementation period: 21-12-2022 to 30-09-2023. Budget: EUR 456,193.5 – Aid: EUR 342,150.00

European Regional Development Fund (ERDF)
A way of doing Europe

Cookies

Le informamos que utilizamos cookies propias y de terceros para ofrecerte un mejor servicio, de acuerdo con tus hábitos de navegación. Si continuas navegando, consideramos que aceptas su uso. Puedes consultar nuestra Política de Cookies.

ACEPTAR